# Extension Study for Patients Entered Into Study Infacort 003

> **NCT02733367** · PHASE3 · COMPLETED · sponsor: **Neurocrine UK Limited** · enrollment: 18 (actual)

## Conditions studied

- Adrenal Insufficiency

## Interventions

- **DRUG:** Infacort®

## Key facts

- **NCT ID:** NCT02733367
- **Lead sponsor:** Neurocrine UK Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-04
- **Primary completion:** 2018-08-10
- **Final completion:** 2018-08-10
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2019-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02733367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02733367, "Extension Study for Patients Entered Into Study Infacort 003". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02733367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*